-transparent.png){kind=logo}
Posttransplant hematologic recovery was compared between 9 autologous and 11 allogeneic marrow transplant patients who received similar marrow-lethal chemoradiotherapies before transplantation. Although the autotransplant patients were infused with much lower marrow doses compared with the allotransplant patients, they showed adequate hematologic recovery with acceptable risk. Regardless of marrow doses, delayed platelet recovery and failure of platelet recovery were observed in 7 patients. All of these patients experienced early transplantation-related complications before engraftment. Despite the limited number of patients, a number of myeloid progenitor cells (CFUC) infused correlated significantly with the period for recovery of polymorphonuclear cells in autologous marrow recipients while there was no significant correlation found between marrow dose and hematologic recovery in both groups of patients. Furthermore, autotransplant patients showed a characteristic recovery pattern of peripheral blood lymphocytes in an early posttransplant period, whic was not observed in allotransplant patients.
M Harada, and
T Yoshida, and
C Ishino, and
K Matsue, and
H Kodo, and
T Mori, and
S Shiobara, and
K Odaka, and
S Ohtake, and
K Kondo
August 1985,
Transplantation,
M Harada, and
T Yoshida, and
C Ishino, and
K Matsue, and
H Kodo, and
T Mori, and
S Shiobara, and
K Odaka, and
S Ohtake, and
K Kondo
April 1986,
New York state journal of medicine,
M Harada, and
T Yoshida, and
C Ishino, and
K Matsue, and
H Kodo, and
T Mori, and
S Shiobara, and
K Odaka, and
S Ohtake, and
K Kondo
November 1988,
Canadian family physician Medecin de famille canadien,
M Harada, and
T Yoshida, and
C Ishino, and
K Matsue, and
H Kodo, and
T Mori, and
S Shiobara, and
K Odaka, and
S Ohtake, and
K Kondo
November 1993,
Bone marrow transplantation,
M Harada, and
T Yoshida, and
C Ishino, and
K Matsue, and
H Kodo, and
T Mori, and
S Shiobara, and
K Odaka, and
S Ohtake, and
K Kondo
January 1990,
Progress in clinical and biological research,
M Harada, and
T Yoshida, and
C Ishino, and
K Matsue, and
H Kodo, and
T Mori, and
S Shiobara, and
K Odaka, and
S Ohtake, and
K Kondo
April 1991,
Current opinion in oncology,
M Harada, and
T Yoshida, and
C Ishino, and
K Matsue, and
H Kodo, and
T Mori, and
S Shiobara, and
K Odaka, and
S Ohtake, and
K Kondo
January 2012,
Journal of clinical and experimental hematopathology : JCEH,
M Harada, and
T Yoshida, and
C Ishino, and
K Matsue, and
H Kodo, and
T Mori, and
S Shiobara, and
K Odaka, and
S Ohtake, and
K Kondo
January 2001,
Bone marrow transplantation,
M Harada, and
T Yoshida, and
C Ishino, and
K Matsue, and
H Kodo, and
T Mori, and
S Shiobara, and
K Odaka, and
S Ohtake, and
K Kondo
May 1976,
Experimental hematology,
M Harada, and
T Yoshida, and
C Ishino, and
K Matsue, and
H Kodo, and
T Mori, and
S Shiobara, and
K Odaka, and
S Ohtake, and
K Kondo
June 1986,
Blood,
